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INTRODUCTION
Renal cell carcinoma (RCC) is the most common malignant tu-
mor in the kidney, accounting for 85% of renal tumors. The in-
cidence of RCC has increased at a rate of 2% annually for the 
past two decades.1 Small RCC is diagnosed more frequently due 
to abdominal imaging, such as ultrasonography, and comput-
ed tomography (CT) is used more widely for various medical 
disorders.2 Renal tumors of ≤7 cm that are confined to the kid-
ney are graded as stage T1, according to the guidelines of the 7th 
Edition of the American Joint Committee on Cancer (AJCC) Can-
cer Staging Manual.3 Some clinical T1 stage RCC tumors invade 
renal sinus fat up to 15.4%.4-6 Renal sinus fat is a fatty area with-
in the kidney that contains many vessels and lymphatic chan-
nels, and is not separated from the renal cortex by the capsule. 
Tumor invasion into renal sinus fat may increase the risk of me-
tastasis, and is related to poor prognosis.7,8 RCC with sinus fat in-
vasion (SFI) is defined as stage T3a, according to the tumor, node, 
and metastases system.3
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Purpose: Computed tomography (CT) is the most useful diagnostic modality for staging renal cell carcinoma (RCC). However, 
CT is limited in its ability to predict renal sinus fat invasion (SFI). Here, we aimed to evaluate whether preoperative neutrophil-to-
lymphocyte ratio (NLR) could predict pathological SFI in patients with RCC of ≤7 cm for whom preoperative imaging reveals po-
tential renal SFI.
Materials and Methods: We reviewed the medical records of 1311 patients who underwent extirpative renal surgery for non-meta-
static RCC of ≤7 cm between November 2005 and December 2014. After excluding patients with no SFI in preoperative imaging, un-
available preoperative data, and morbidity affecting inflammatory markers, a total of 476 patients were included in this study. Mul-
tivariate logistic regression analysis was used to evaluate predictors of pathological SFI.
Results: We implemented a cut-off value of 1.98, which was calculated by ROC analysis to obtain high (≥1.98) and low (<1.98) NLR 
groups. A total of 93 patients with pathological SFI had larger clinical tumor size, higher preoperative NLR, larger pathological tu-
mor size, more frequent renal vein involvement, and higher Fuhrman nuclear grade. Multivariate analysis indicated that high NLR 
[odds ratio (OR) 2.032, p=0.004], clinical tumor size (OR 1.586, p<0.001), and collecting system involvement on preoperative imag-
ing (OR 3.957, p=0.011) were significantly associated with pathological SFI in these tumors.
Conclusion: Preoperative high NLR was associated with pathological SFI in patients with RCC of ≤7 cm and presumed SFI on pre-
operative imaging. Greater surgical attention is needed to obtain negative margins during partial nephrectomy in these patients.
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CT is one of the most widely used modalities for characteriz-
ing and staging renal tumors. Multidetector computed tomog-
raphy (MDCT) has allowed radiologists to overcome the limi-
tations of single-detector helical CT by providing volume data 
that can be reformatted in various planes, which helps to deter-
mine the boundaries of complex renal tumors. However, MDCT 
provides only limited information for predicting pathological 
SFI in renal tumors.9
C-reactive protein (CRP), a serum marker for systemic inflam-
mation, was recently reported as a good prognostic marker in 
patients with RCC.10,11 However, CRP data are not readily avail-
able for all patients, as it requires additional serum testing. There-
fore, other systemic inflammatory markers, such as lymphocyte-
to-monocyte ratio or neutrophil-to-lymphocyte ratio (NLR), have 
been used in many studies.12,13 NLR correlates well with serum 
CRP levels,13 and it is easily calculated from a complete blood 
count with differential by dividing the absolute neutrophil count 
by the absolute lymphocyte count. NLR has been reported to 
predict oncological outcomes in patients with RCC.14,15 In this 
study, we aimed to evaluate whether NLR could predict path-
ological SFI in RCC of ≤7 cm that appeared to invade the renal 
sinus fat on preoperative imaging.
MATERIALS AND METHODS
Patient selection
We retrospectively reviewed the medical records of 1311 patients 
who underwent partial or radical nephrectomy for RCC of ≤7 cm 
between November 2005 and December 2014. After the patients 
with insufficient preoperative image for diagnosing SFI and 
lacked preoperative data, patients who did not have SFI in pre-
operative imaging and were diagnosed with node positive or 
metastatic (N1 or M1) disease were excluded. Patients also 
were excluded if they had any factors that could affect NLR, in-
cluding simultaneous diagnosis of other malignancy, infec-
tious disease, autoimmune or systemic inflammatory diseases, 
and the use of chemotherapeutic agents or immunosuppres-
sants. Patients also were excluded if they had abnormal com-
plete blood count. Our institution sets the normal range of hae-
moglobin levels from 14.0 g/dL to 17.4 g/dL in men and 11.7 g/
dL to 16.0 g/dL in women, white blood cell range from 4000/μL 
to 10800/μL, and platelet range from 150000/μL to 400000/
μL. Finally, 476 patients were enrolled in our study (Fig. 1). We 
evaluated the age, gender, body mass index (BMI), hyperten-
sion, smoking status, preoperative NLR, radiological informa-
tion from preoperative CT, and pathology results. Preoperative 
NLR was calculated by dividing the absolute neutrophil count 
by the absolute lymphocyte count, which were obtained from 
routine laboratory tests within 1 month before nephrectomy. 
Retrospective data collection was approved by the Institution-
al Review Board of the Yonsei University Health System (Ap-
proval No. 4-2018-0215).
CT data interpretation
CT images were obtained using a 64-slice detector (Sensation 
64, Siemens, Erlangen, Germany) to identify renal tumors with 
SFI. One senior uro-radiologist (Young Taik Oh) and one se-
nior urologist (WS Ham) retrospectively reviewed and evaluat-
ed the CT images, independently. They were informed that all 
patients included in the study were diagnosed with RCC, al-
though no information was given about the size, location, 
stage, or renal sinus involvement of the tumor. Interobserver 
variation was evaluated using Cohen’s kappa statistical analysis; 
the kappa coefficient was 0.95 (p<0.05), indicating a high coin-
cidence of SFI diagnosis between the two reviewers. If the re-
viewers had different opinions regarding SFI, the final decision 
was reached after both reviewers reviewed the images togeth-
er. The anatomical characteristics of tumors were collected 
based on the preoperative aspects and dimensions used for an 
anatomical (PADUA) classification, which contains SFI infor-
mation. The criteria used for SFI diagnosis on preoperative im-
aging included tumor extension into the renal sinus, proximity 
to the pelvicalyceal system, and invasion of the pelvicalyceal 
system. Collecting system involvement on preoperative imag-
ing was defined as a renal tumor infiltrating or dislocating a 
1279 patients remained
514 patients remained
476 patients were included 
in this analysis
480 patients remained
32 patients had insufficient 
preoperative image and lacked 
preoperative data
765 patients without sinus fat
invasion in preoperative imaging
4 patients with abnormal 
complete blood count
24 patients with N1 or M1 disease
10 patients with factors that could 
affect neutrophil-lymphocyte ratio
- 5 patients with other malignancy
- 2 patients with infectious disease
-  1 patient with auto-immune or 
systemic inflammatory disease
-  2 patients used chemotherapeutic 
agent or immunosuppressant usage
490 patients remained
Fig. 1. Flow chart of patient selection.
1311 patients underwent nephrectomy 
due to renal cell carcinoma 
≤7 cm between November 2005 and 
December 2014
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collecting system.16
Pathology analysis
Pathology outcomes were obtained by reviewing medical re-
cords and previous pathology reports that had been prepared 
by a single genitourinary pathologist (Nam Hoon Cho) at Yon-
sei University. Pathological SFI was defined as direct contact of 
cancer cells with the renal sinus stroma or fat cells. Tumors in-
filtrating the pelvicalyceal system were also classified as SFI. Tu-
mors confined by a pseudocapsule bulging into renal sinus fat 
without clear evidence of infiltration were not classified as SFI.
Statistical analysis
Baseline characteristics of patients and tumors were compared 
between patients with no SFI and those with SFI using descrip-
tive statistics. Mann—Whitney U-test and Fisher’s exact test were 
used to compare continuous and categorical variables, respec-
tively. Binomial logistic regression analysis was used to identi-
fy factors associated with pathological SFI. A receiver operating 
characteristic (ROC) curve was used to analyse the ability of 
NLR to predict pathological SFI. After identifying the predictors 
of pathological SFI, we plotted ROC curves including all factors 
related to pathological SFI, and another set of ROC curves with 
all covariates except NLR. We compared the area under the curve 
(AUC) of the two ROC curves to determine the predictive abil-
ity of NLR. Recurrence-free survival (RFS) was compared using 
Kaplan—Meier curves with log-rank test. Statistical analysis was 
performed using SPSS version 25 (IBM Corp., Armonk, NY, USA).
Table 1. Clinicopathological Characteristics of Patients
Characteristics Total (n=476) Without SFI (n=383) With SFI* (n=93) p value
Preoperative variables
Gender (n, %) 0.538
Male 321 (67.4) 261 (68.1) 60 (64.5)
Female 155 (32.6) 122 (31.9) 33 (35.5)
Age (median, IQR) 55 (46.0–64.0) 54 (45.0–63.0) 58 (48.5–64.0) 0.049
BMI (median, IQR) 24.2 (22.40–26.20) 24.1 (22.50–26.23) 24.4 (21.75–26.20) 0.567
Hypertension (n, %) 191 (40.1) 150 (39.2) 41 (44.1) 0.410
DM (n, %) 69 (14.5) 52 (13.6) 17 (18.3) 0.253
Current or former smoker (n, %) 208 (43.7) 175 (45.7) 33 (35.5) 0.081
Clinical tumor size (median, IQR) 4.6 (3.60–5.60) 4.4 (3.50–5.40) 5.5 (4.35–6.35) <0.001
Collecting system involvement (n, %)† 413 (86.8) 324 (84.6) 89 (95.7) 0.006
Type of nephrectomy (n, %) 0.569
Radical nephrectomy 334 (70.2) 271 (70.8) 63 (67.7)
Partial nephrectomy 142 (29.8) 112 (29.2) 30 (32.3)
NLR (median, IQR) 1.9 (1.39–2.53) 1.85 (1.38–2.38) 2.22 (1.46–3.35) <0.001
NLR (dichotomous) (n, %) 0.002
High NLR 259 (54.4) 222 (58.0) 37 (39.8)
Low NLR 217 (45.6) 161 (42.0) 56 (60.2)
Postoperative variables
Pathological tumor size (median, IQR) 4.2 (3.3–5.5) 4.0 (3.2–5.0) 5.0 (4.00–6.00) <0.001
Histological subtype (n, %) 0.292
Clear cell 417 (87.6) 339 (88.5) 78 (83.9)
Non-clear cell 59 (12.4) 44 (11.5) 15 (16.1)
Fuhrman nuclear grade (n, %) <0.001
G1–2 226 (47.5) 200 (52.2) 26 (27.9)
G3–4 223 (46.8) 165 (43.1) 58 (62.4)
Unknown 27 (5.7) 18 (4.7) 9 (9.7)
Perinephric fat invasion (n, %)‡ 30 (6.3) 20 (5.2) 10 (10.8) 0.058
Renal vein or branch invasion (n, %)‡ 14 (2.9) 3 (0.8) 11 (11.8) <0.001
Positive surgical margin (n, %)§ 14 (9.9) 6 (5.4) 8 (26.7) 0.002
Sarcomatoid differentiation (n, %) 6 (1.3) 5 (1.3) 6 (6.5) 0.999
SFI, sinus fat invasion; IQR, interquartile range; BMI, body mass index; DM, diabetes mellitus; NLR, neutrophil-to-lymphocyte ratio.
Values are presented as median (range) or n (%) unless otherwise indicated.
*Pathological renal sinus fat invasion; †Clinical findings on preoperative imaging; ‡Pathology findings; §Among 142 patients underwent partial nephrectomy.
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RESULTS
Table 1 presents the clinical and pathological characteristics of 
patients. There were 321 male and 155 female patients with a 
median age of 55 years [interquartile range (IQR) 46.0–64.0]. The 
median clinical tumor size was 4.6 cm (IQR 3.6–5.6). The me-
dian value of NLR was 1.90 (IQR 1.39–2.53). SFI was observed 
in 93 of the 476 patients. NLR cut-off value was determined as 
1.98, which was calculated by ROC analysis. AUC based on SFI 
was 0.615. NLR was evaluated as a dichotomised variable by 
dividing the observed cases into two groups (NLR <1.98 and 
NLR ≥1.98).
Although the tumors of all 476 patients were presumed to in-
vade the renal sinus fat on preoperative imaging, only 93 patients 
(19.5%) had pathological SFI. Older patients were more likely to 
have pathological renal SFI, and clinical tumor size was larger 
in the pathological SFI group (5.5 cm vs. 4.4 cm, p<0.001). Col-
lecting system involvement on preoperative CT was more fre-
quently observed in SFI group (95.7% vs. 84.6%, p=0.006). The 
median preoperative NLR value was higher in SFI group (2.22 
vs. 1.85, p<0.001). There was no difference in the rate of partial 
nephrectomy (PN) between the two groups (32.3% vs. 29.2%, p= 
0.569), but the incidence of positive surgical margin was higher 
in SFI group (26.7% vs. 5.4%, p<0.001) among patients underwent 
PN. The pathology results for SFI group showed larger tumor 
size (5.0 cm vs. 4.0 cm, p<0.001) and higher rate of high-grade 
(Fuhrman nuclear grade 3–4) RCC (62.4% vs. 43.1%, p<0.001). 
SFI group also had more renal vein involvement (11.8% vs. 0.8%, 
p<0.001).
We performed univariate binary logistic regression analysis to 
evaluate preoperative factors associated with pathological SFI 
in these tumors, and found that age [odds ratio (OR)=1.019, 95% 
confidence interval (CI) 1.000–1.039, p=0.05], clinical tumor size 
(OR=1.645, 95% CI 1.360–1.990, p<0.001), collecting system in-
volvement on preoperative imaging (OR=4.052, 95% CI 1.433–
11.457, p=0.008), and NLR (OR=2.087, 95% CI 1.315–3.313, p= 
0.002) were associated with SFI. In multivariate analysis, clini-
cal tumor size (OR=1.586, 95% CI 1.305–1.926, p<0.001), collect-
ing system involvement on preoperative imaging (OR=3.957, 
95% CI 1.371–11.417, p=0.011), and high NLR (OR=2.032, 95% 
CI 1.256–3.287, p=0.004) were independent predictors of path-
ological SFI (Table 2).
To assess the predictive power of NLR, we defined prediction 
model 1 to include clinical tumor size and collecting system in-
volvement, whereas prediction model 2 included an additional 
factor of preoperative NLR. Then, we compared the AUCs of these 
two predictive models, which were 0.693 and 0.720 for model 
1 and model 2, respectively (Fig. 2).
Fig. 3 showed Kaplan-Meier curves of RFS according to NLR 
and pathologic SFI. With median follow-up 79 months, 5-year 
RFS was worse in high NLR group (87.8% vs. 93.8%, p=0.019) 
and having pathologic SFI group (79.5% vs. 93.9%, p<0.001).
DISCUSSION
Renal sinus is a cavity within the kidney that is formed by exten-
sion of the perinephric space into the deep recess located at the 
Table 2. Univariate and Multivariate Analyses to Evaluate Preoperative Factors associated with Pathological Renal Sinus Fat Invasion
Variable
Univariate analysis Multivariate analysis
OR (95% CI) p value OR (95% CI) p value
Gender 0.503
Male 1 (Ref)
Female 1.177 (0.732–1.894)
Age 1.019 (1.000–1.039) 0.050 1.014 (0.994–1.035) 0.168
BMI 1.021 (0.952–1.094) 0.566
Hypertension 0.386
No 1 (Ref)
Yes 1.225 (0.775–1.936)
Smoking 0.076
Non-smoker 1 (Ref)
Current or former smoker 0.654 (0.409–1.046)
Clinical tumor size 1.645 (1.360–1.990) <0.001 1.586 (1.305–1.926) <0.001
Collecting system involvement* 0.008 0.011
Not involved 1 (Ref) 1 (Ref)
Involved 4.052 (1.433–11.457) 3.957 (1.371–11.417)
NLR 0.002 0.004
Low 1 (Ref) 1 (Ref)
High 2.087 (1.315–3.313) 2.032 (1.256–3.287)
OR, odds ratio; CI, confidence interval; BMI, body mass index; NLR, neutrophil-to-lymphocyte ratio; Ref, reference.
*Clinical findings on preoperative imaging.
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medial border of the kidney. Major branches of renal artery and 
vein along with the major and minor calices of collecting system 
are located within the renal sinus. Renal sinus also contains abun-
dant lymphatic channels with adipose tissue and nerve fibres.8 
Unlike perirenal tissue, renal sinus is not separated from the re-
nal cortex by a capsule. Therefore, tumor invasion into the renal 
sinus means that the tumor has higher chance to spread. Many 
studies showed that renal sinus invasion has poor prognosis. 
Thompson, et al.7 reported that the survival rate of patients who 
had RCC with SFI was poorer compared to patients who had 
RCC without SFI. Bertini, et al.17 assessed the impact of renal si-
nus fat sinus invasion on oncological outcome in pT3a clear cell 
RCC, and found that SFI was significantly negatively associated 
with cancer-specific survival in patients without lymph node or 
distant metastasis.
Since renal sinus invasion is associated with oncological out-
come, predicting SFI is important to predict the prognosis of RCC 
patients. CT is the gold standard imaging modality for diagnos-
ing RCC, and it provides information such as tumor size, loca-
tion, and the anatomy of adjacent structures. CT may help to 
diagnose T stage, but it is limited for diagnosing renal sinus in-
vasion.18 Some studies reported that CT sensitivity ranged from 
71.0–81.8% and CT specificity ranged from 71.0–91.7%.9,19 In our 
study, only 19.7% of patients had pathological SFI.
NLR is a prognostic factor in numerous cancers including 
RCC, although the specific mechanism for this relationship is not 
completely understood. Several studies reported that chronic 
inflammation has a key role in carcinogenesis.20 Neutrophils play 
a major role in pro-tumoral activity by secreting substances such 
as derivatives of reactive oxygen species or vascular endothelial 
growth factors,21 whereas lymphocytes reflect cell-mediated im-
munity with antitumoral properties.22 Therefore, high NLR po-
tentially contributes to aggressive tumor biology and progres-
sion and poor survival.
Other studies showed that tumor-derived inflammation can 
increase myelopoiesis with defective myeloid cell differentiation 
and proliferation by regulating the bone marrow and spleen, 
leading to the accumulation of immature myeloid cells in the 
peripheral circulation.23 Myeloid cells play a critical role in tu-
mor pathogenesis by promoting cancer cell proliferation, tumor 
angiogenesis, cell invasion, and metastasis. In the case of cancer-
mediated myelopoiesis, myelocytes and promyelocytes (neu-
Fig. 3. Kaplan-Meier curve of recurrence-free survival according to neutrophil-lymphocyte ratio (A) and pathologic sinus fat invasion (SFI) (B). NLR, neu-
trophil-to-lymphocyte ratio.
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1.0
0.8
0.6
0.4
0.2
0.0
0.0 0.2 0.4 0.6 0.8 1.0
1-specificity
Se
ns
iti
vit
y
Prediction model 1 Prediction model 2 Reference
1026
NLR as a Predictor of Renal Sinus Fat Invasion
https://doi.org/10.3349/ymj.2019.60.11.1021
trophil precursors) proliferate are released into the peripheral 
blood. Neutrophils are the most abundant granulocytes, which 
account for most peripheral white blood cells.24 Therefore, the 
prognostic and predictive value of peripheral neutrophils as an 
independent index or as part of NLR in cancers is apparent, and 
enhanced neutrophil responses and/or lymphocyte suppres-
sion, leading to a high NLR, might promote tumor progression 
and inhibit the antitumor immune response.
Many studies demonstrated that NLR was a biomarker with 
a prognostic value for RCC. Sejima, et al.25 reported an associa-
tion between NLR and local Fas ligand (FasL) expression. FasL 
is a surface receptor involved in cell apoptosis via the action of 
cytotoxic T cell. Low NLR was correlated with a high expression 
level of FasL, which was related to improved overall survival (OS). 
In locally advanced or metastatic RCC, higher preoperative NLR 
was associated with poorer OS in many studies.26,27 The study 
by de Martino, et al.14 reported that high preoperative NLR was 
associated with poorer disease-free survival (DFS) in patients 
with localized RCC. Viers, et al.15 also showed that preoperative 
NLR was a significant prognostic factor of OS and DFS in local-
ized RCC. Therefore, we assessed whether NLR could predict 
pathological SFI, which is related to worse oncological outcomes, 
in cancers with few predictive factors of SFI. In this study, pre-
operative NLR was associated with pathological SFI, tumor size, 
and collecting system involvement on preoperative imaging. 
Adding preoperative NLR to our predictive model, along with 
tumor size and collecting system involvement on preoperative 
imaging, increased the AUC from 0.693 to 0.720. This indicates 
that preoperative NLR is helpful, although limited, in diagnos-
ing SFI. 
Our results showed that 29.8% of patients with suspected SFI 
underwent PN. In our institution, the surgical method for RCC 
is usually determined by the surgeon’s preference, and some fac-
ulties have performed PN for renal masses more than 4 cm or 
presumed SFI for many years. We previously reported equivalent 
oncological outcomes for PN and radical nephrectomy when 
clear surgical margins can be obtained in these tumors.18 There-
fore, if SFI is suspected on preoperative imaging with high NLR, 
there should be greater intention for the surgeon to secure neg-
ative surgical margins during PN.
Our study had some limitations. First, due to the study’s ret-
rospective and non-randomized nature, some selection bias 
may have occurred in our results. We tried to overcome this lim-
itation by allowing the two reviewers to judge the presence of 
SFI from preoperative images without informing them of the 
patients’ SFI outcome. However, our criteria for SFI diagnosis 
were liberal, as only 19.5% of the enrolled cases had pathologi-
cal SFI in clinical T3a stage tumors. This result means that it is 
not sufficient to diagnose SFI using only preoperative CT, and 
also implies that other predictors for SFI are needed. The long 
duration of study could also be a limitation. Our study included 
patients who underwent surgery over a period of more than 10 
years, during which there would have been some progress in the 
technique of imaging. We tried to overcome this disadvantage 
by excluding patients with images of insufficient quality to read 
SFI. We did not perform a second review of the pathology spec-
imen, although it is difficult to diagnose SFI with specimen ob-
tained by PN. This was due to our policy that the retention pe-
riod of specimens obtained after surgery is 10 years, and the 
majority of old formalin-fixed paraffin-embedded tissue were 
difficult to read due to poor quality. This might have been a rea-
son for our clinical over-staging. Our results were derived using 
data from Severance Hospital, so it may not be generalizable. 
Further prospective and multicenter studies are needed to con-
firm our results.
In conclusion, preoperative high NLR, along with tumor size 
and collecting system involvement, on preoperative imaging 
was associated with pathological SFI in patients with RCC of 
≤7 cm with presumed SFI on preoperative imaging. Patients with 
these preoperative findings require greater attention to obtain 
negative surgical margins during PN.
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